They measured N-acetylornithine levels and found that they were correlated with renal function in their study populations, suggesting a potential role for this metabolite in chronic renal insufficiency. Of interest, six of their 37 genome-wide significant associations to metabolites have previously been related to adverse drug effects; further study of these metabolites and their genetic determinants could provide insight into the mechanisms for drug toxicity.
